STOCK TITAN

[SCHEDULE 13G] China SXT Pharmaceuticals, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Percentage of class is calculated based on 116,027,758 Ordinary Shares outstanding as of July 29, 2025, which information was provided by the Issuer to the Reporting Person on July 29, 2025. Given that as of July 29, 2025, the Issuer has 116,027,758 Ordinary Shares outstanding, comprising 116,027,226 Class A Ordinary Shares, each entitled to one vote, and 532 Class B Ordinary Shares, each entitled to fifty votes, the total voting power of the Issuer is 116,053,826 votes. The Reporting Person holds 10,588,240 Class A Ordinary Shares, representing approximately 9.12% of the total voting power of the Issuer.


SCHEDULE 13G



FOONG SOON HONG, RANDY
Signature:/s/ FOONG SOON HONG, RANDY
Name/Title:FOONG SOON HONG, RANDY
Date:08/07/2025
China Sxt Pharmaceuticals Inc

NASDAQ:SXTC

SXTC Rankings

SXTC Latest News

SXTC Latest SEC Filings

SXTC Stock Data

157.80M
75.04M
35.33%
0.07%
0.04%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
China
Taizhou